Vestech has been working with Headsafe, led by Dr Adrian Cohen, a senior lecturer at the University of Sydney to develop a practical, immediate and reliable means of assessing visual evoked potentials (VEPs) in a real world setting. Typically VEPs are measured in a lab and take some time, this new method takes two minutes […]
Vestech helps achieve CE Mark, TGA approval and FDA clearance for Cryptych’s innovative spinal implant.
James Poyitt, a 16 year old school student visited Vestech, along with his father Stewart Poyitt for advice on his innovative leg rehabilitation device. James had been selected to present his invention in Phoenix Arizona at the Intel International Science and Technology Fair – a huge honour. Vestech’s Dr Roger assisted them with weighing up the […]
Dr Greg Roger, CEO of Vestech, was appointed to the Buck Advisory Committee (www.thebuck.org) following the Board’s meeting in Singapore in October 2015. He subsequently attended the BAC meeting in San Francisco in May 2016, meeting with Dr Dale Bredesen, pioneer in early Alzheimers treatment and other fellow BAC members including Deepak Chopra, Cherilyn Murer and […]
Dr Carlotta Duncan, the Director for Scientific Advancement at the Buck Institute for Research on Ageing, gave Vestech’s CEO, Dr Greg Roger a tour of the Institute’s facility in Novato California.
Following his meetings at BIO Dr Roger was able to meet with the CEO of CONNECT, Greg McKee, to explore collaborations between this US-wide, Californian based innovation network and Australian firms wishing to export to the USA.
On a recent trip to New Zealand, Dr Roger met with David Budgett, Associate Professor, Technology Development Leader Auckland Bioengineering Institute (ABI) at the University of Auckland. Dr Roger was able to review the ABIs world-class research in tissue modeling and inducted power sources for medical devices.